Outcome of Allogeneic Stem Cell Transplantation in Myelodysplastic Syndrome Patients: Prognostic implication of monosomal karyotype
European Journal of Haematology, 07/05/2012
Wudhikarn K et al. – Cytogenetic abnormalities remain an important prognostic factor for allotransplant outcome of myelodysplastic syndromes (MDS). The results suggested poor allotransplant outcomes with high relapse incidence (RI) and low overall survival (OS) in MDS with Monosomal karyotype (MK).